DoubleBond Pharmaceutical AB (publ) ("DBP") reports the final data from its extensive retrospective study of Temodex, confirming a statistically significant 5.6-month survival advantage for patients with malignant primary brain tumors.
) Display copy. Rules of the Secure Trust Bank 2026 Deferred BonusPlan. Approved by the shareholders of Secure trust BankPLC on. [X] 2026. Approved by the board of directors of Secure Trust Bank PLC through its Remuneration Committee on [X] 2026 ... ii ... .